Chinese Journal of Dermatology ›› 2018, Vol. 51 ›› Issue (6): 403-408.doi: 10.3760/cma.j.issn.0412-4030.2018.06.001
• Guidelines and Consensus • Next Articles
,
Received:2018-03-12
Revised:2018-04-28
Online:2018-06-15
Published:2018-05-30
| ［1］ | Bao L, Wei G, Gan H, et al. Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine［J］. Exp Ther Med, 2016,11（5）:1788⁃1794. doi: 10.3892/etm.2016.3086.<br /> |
| ［2］ | Gershon AA, Gershon MD, Breuer J, et al. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster［J］. J Clin Virol, 2010,48（Suppl 1）:S2⁃7. doi: 10.1016/S1386⁃6532（10）70002⁃0.<br /> |
| ［3］ | Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella⁃zoster virus infections［J］. Eur J Clin Microbiol Infect Dis, 2016,35（5）:723⁃734. doi: 10.1007/s10096⁃016⁃2605⁃0.<br /> |
| ［4］ | Yawn BP, Gilden D. The global epidemiology of herpes zoster［J］. Neurology, 2013,81（10）:928⁃930. doi: 10.1212/WNL.0b013e3182a 3516e.<br /> |
| ［5］ | Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective［J］. BMJ Open, 2014,4（6）:e004833. doi: 10.1136/bmjopen⁃2014⁃004833.<br /> |
| ［6］ | Chen LK, Arai H, Chen LY, et al. Looking back to move forward: a twenty⁃year audit of herpes zoster in Asia⁃Pacific［J］. BMC Infect Dis, 2017,17（1）:213. doi: 10.1186/s12879⁃017⁃2198⁃y.<br /> |
| ［7］ | Kawai K, Yawn BP, Wollan P, et al. Increasing incidence of herpes zoster over a 60⁃year period from a population⁃based study［J］. Clin Infect Dis, 2016,63（2）:221⁃226. doi: 10.1093/cid/ciw296.<br /> |
| ［8］ | Bricout H, Haugh M, Olatunde O, et al. Herpes zoster⁃associated mortality in Europe: a systematic review［J］. BMC Public Health, 2015,15:466. doi: 10.1186/s12889⁃015⁃1753⁃y.<br /> |
| ［9］ | Yenikomshian MA, Guignard AP, Haguinet F, et al. The epidemi⁃ology of herpes zoster and its complications in Medicare cancer patients［J］. BMC Infect Dis, 2015,15:106. doi: 10.1186/s12879⁃015⁃0810⁃6.<br /> |
| ［10］ | Grabar S, Tattevin P, Selinger⁃Leneman H, et al. Incidence of herpes zoster in HIV⁃infected adults in the combined antiretro⁃viral therapy era: results from the FHDH⁃ANRS CO4 cohort［J］. Clin Infect Dis, 2015,60（8）:1269⁃1277. doi: 10.1093/cid/ciu1161.<br /> |
| ［11］ | Zhu Q, Zheng H, Qu H, et al. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China［J］. Hum Vaccin Immunother, 2015,11（8）:2113⁃2118. doi: 10.1080/21645515.2015.1016672.<br /> |
| ［12］ | Lin YH, Huang LM, Chang IS, et al. Disease burden and epidemiology of herpes zoster in pre⁃vaccine Taiwan［J］. Vaccine, 2010,28（5）:1217⁃1220. doi: 10.1016/j.vaccine.2009.11.029.<br /> |
| ［13］ | 朱学骏, 王宝玺, 孙建方, 等. 皮肤病学［M］. 2版. 北京: 北京大学医学出版社, 2011:1483⁃1494.<br /> |
| ［14］ | 张建中. 中外皮肤病诊疗指南［M］. 北京: 中华医学电子音像出版社, 2014:86⁃94.<br /> |
| ［15］ | Jeon YH. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment［J］. Korean J Pain, 2015,28（3）:177⁃184. doi: 10.3344/kjp.2015.28.3.177.<br /> |
| ［16］ | Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia［J］. Cochrane Database Syst Rev, 2014,（2）:CD006866. doi: 10.1002/14651858.CD006866.pub3.<br /> |
| ［17］ | Lamoureux C, Flatrès C, Vallet S, et al. Aseptic meningitis caused by the Varicella⁃zoster virus after primary infection in an immunocompetent child: a case report［J］. Ann Biol Clin （Paris）, 2018,76（2）:234⁃236. doi: 10.1684/abc.2018.1331.<br /> |
| ［18］ | Werner RN, Nikkels AF, Marinovic B, et al. European consensus⁃based （S2k） Guideline on the Management of Herpes Zoster ⁃ guided by the European Dermatology Forum （EDF） in coope⁃ration with the European Academy of Dermatology and Venereology （EADV）, Part 2: Treatment［J］. J Eur Acad Dermatol Venereol, 2017,31（1）:20⁃29. doi: 10.1111/jdv.13957.<br /> |
| ［19］ | Yoon H, Rhew KY. Famciclovir as an antiviral agent for a patient with acute renal failure［J］. Int J Clin Pharm, 2013,35（2）:173⁃175. doi: 10.1007/s11096⁃012⁃9737⁃9.<br /> |
| ［20］ | Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America［J］. Clin Infect Dis, 2008,47（3）:303⁃327. doi: 10.1086/589747.<br /> |
| ［21］ | Duda JF, Castro JG. Bilateral retrobulbar optic neuritis caused by Varicella zoster virus in a patient with AIDS［J］. Br J Med Med Res, 2015,5（11）:1381⁃1386. doi: 10.9734/BJMMR/2015/14259.<br /> |
| ［22］ | Whitley RJ, Cloud G, Gruber W, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group［J］. J Infect Dis, 1997,175（5）:1080⁃1086.<br /> |
| ［23］ | Han Y, Zhang J, Chen N, et al. Corticosteroids for preventing postherpetic neuralgia［J］. Cochrane Database Syst Rev, 2013,（3）:CD005582. doi: 10.1002/14651858.CD005582.pub4.<br /> |
| ［24］ | Watanabe D, Mizukami A, Holl K, et al. The potential public health impact of herpes zoster vaccination of people aged ≥ 50 years in Japan: results of a Markov model analysis［J］. Dermatol Ther （Heidelb）, 2018. doi: 10.1007/s13555⁃018⁃0236⁃3.<br /> |
| ［25］ | Gan EY, Tian EA, Tey HL. Management of herpes zoster and post⁃herpetic neuralgia［J］. Am J Clin Dermatol, 2013,14（2）:77⁃85. doi: 10.1007/s40257⁃013⁃0011⁃2.<br /> |
| ［26］ | Lapolla W, Digiorgio C, Haitz K, et al. Incidence of postherpetic neuralgia after combination treatment with gabapentin and vala⁃cyclovir in patients with acute herpes zoster: open⁃label study［J］. Arch Dermatol, 2011,147（8）:901⁃907. doi: 10.1001/archdermatol. 2011.81.<br /> |
| ［27］ | Migita T. Can early administration of pregabalin reduce the incidence of postherpetic neuralgia?［J］. Clin Exp Dermatol, 2014,39（6）:755⁃756. doi: 10.1111/ced.12386.<br /> |
| ［28］ | Liang L, Li X, Zhang G, et al. Pregabalin in the treatment of herpetic neuralgia: results of a multicenter Chinese study［J］. Pain Med, 2015,16（1）:160⁃167. doi: 10.1111/pme.12564.<br /> |
| ［29］ | Sáez⁃Llorens X, Yogev R, Arguedas A, et al. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella⁃zoster virus infection［J］. Antimicrob Agents Chemother, 2009,53（5）:1912⁃1920. doi: 10.1128/AAC.01054⁃08.<br /> |
| ［30］ | Kimberlin DW, Jacobs RF, Weller S, et al. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age［J］. Clin Infect Dis, 2010,50（2）:221⁃228. doi: 10.1086/649212.<br /> |
| ［31］ | Rao S, Abzug MJ, Carosone⁃Link P, et al. Intravenous acyclovir and renal dysfunction in children: a matched case control study［J］. J Pediatr, 2015,166（6）:1462⁃1468.e1⁃4. doi: 10.1016/j.jpeds.2015.01.023.<br /> |
| ［32］ | De Paschale M, Clerici P. Microbiology laboratory and the management of mother⁃child varicella⁃zoster virus infection［J］. World J Virol, 2016,5（3）:97⁃124. doi: 10.5501/wjv.v5.i3.97.<br /> |
| ［33］ | 刘巧. 中西医结合皮肤病治疗学［M］. 北京：人民军医出版社,2014,125.<br /> |
| ［34］ | 李成宾, 李芸. 加味龙胆泻肝汤治疗带状疱疹60例［J］.光明中医, 2010,25（5）:800⁃801. doi: 10.3969/j.issn.1003⁃8914.2010.05. 032.<br /> |
| ［35］ | 林燕, 郭晓宇, 栾杨. 带状疱疹的中成药及民间偏方疗法［J］.中国临床医生, 2011,39（8）:20⁃22. doi: 10.3969/j.issn.1008⁃1089.2011.08.009.<br /> |
| ［36］ | 杨志波, 范瑞强, 邓丙戌. 中医皮肤性病学［M］. 北京: 中国中医药出版社, 2010:33.<br /> |
| ［37］ | 王伟芳. 除湿胃苓汤加减治疗脾虚湿蕴型蛇串疮的临床观察［D］. 武汉: 湖北中医药大学, 2012.<br /> |
| ［38］ | 中华中医药学会皮肤科分会. 蛇串疮中医诊疗指南（2014年修订版）［J］.中医杂志, 2015,56（13）:1163⁃1168. doi: 10.13288/j.11⁃2166/r.2015.13.022.<br /> |
| ［39］ | Liu H, Lu F, Zhou D, et al. The analgesic and emotional response to intravenous lidocaine infusion in the treatment of postherpetic neuralgia: a randomized, double⁃blinded, placebo⁃controlled study［J］. Clin J Pain, 2018. doi: 10.1097/AJP. 0000000000000623.<br /> |
| ［40］ | Chen YT, Wang HH, Wang TJ, et al. Early application of low⁃level laser may reduce the incidence of postherpetic neuralgia （PHN）［J］. J Am Acad Dermatol, 2016,75（3）:572⁃577. doi: 10.1016/j.jaad.2016.03.050.<br /> |
| ［41］ | 张学军. 皮肤性病学［M］. 8版. 北京: 人民卫生出版社, 2013:67.<br /> |
| ［42］ | Préaud E, Uhart M, Böhm K, et al. Cost⁃effectiveness analysis of a vaccination program for the prevention of herpes zoster and post⁃herpetic neuralgia in adults aged 50 and over in Germany［J］. Hum Vaccin Immunother, 2015,11（4）:884⁃896. doi: 10.1080/21645515.2015.1011561.<br /> |
| ［43］ | 带状疱疹后神经痛诊疗共识编写专家组. 带状疱疹后神经痛诊疗中国专家共识［J］. 中国疼痛医学杂志, 2016,22（3）:161⁃167. doi: 10.3969/j.issn.1006⁃9852.2016.03.001.<br /> |
| ［44］ | Stratman E. Visceral zoster as the presenting feature of disseminated herpes zoster［J］. J Am Acad Dermatol, 2002,46（5）:771⁃774.<br /> |
| ［45］ | Giovanni G, Nicoletta V, Parvanè K, et al. Prevention of herpes zoster and its complications: from the clinic to the real⁃life experience with the vaccine［J］. J Med Microbiol, 2016,65（12）:1363⁃1369. doi: 10.1099/jmm.0.000386.<br /> |
| ［46］ | Pellissier JM, Brisson M, Levin MJ. Evaluation of the cost⁃effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults［J］. Vaccine, 2007,25（49）:8326⁃8337. doi: 10.1016/j.vaccine.2007.09.066.<br /> |
| ［47］ | Ansaldi F, Trucchi C, Alicino C, et al. Real⁃world effectiveness and safety of a live⁃attenuated herpes zoster vaccine: a comprehensive review［J］. Adv Ther, 2016,33（7）:1094⁃1104. doi: 10.1007/s12325⁃016⁃0355⁃0.<br /> |
| ［48］ | Barnabas RV, Baeten JM, Lingappa JR, et al. Acyclovir prophy⁃laxis reduces the incidence of herpes zoster among HIV⁃infected individuals: results of a randomized clinical trial［J］. J Infect Dis, 2016,213（4）:551⁃555. doi: 10.1093/infdis/jiv318.<br /> |
| No related articles found! |
|
